Intraocular injection equipment
By using rack and rack transmission components and elastic drive parts in intraocular injection equipment, the problem of non-sustainable delivery of medicine in the prior art is solved, the stability and safety of drug injection is achieved, and the pain and medical care of patients are reduced. The difficulty of operation of personnel.
Patent Information
- Application Number
- CN202323120031.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2023-11-20
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2033-11-20
AI Technical Summary
Existing intraocular injection devices are difficult to achieve continuous and stable drug injection during drug delivery, resulting in the risk of repeated puncture of pain and perforation of the eyeballs in patients.
An intraocular injection device is designed, using rack and rack transmission assembly and elastic drive member to achieve stable pushing of drugs through the matching transmission of rack and rack, and reduce operation difficulty through flexible pads and counterweights.
The continuity and uniformity of drug injections are achieved, the pain of patients is reduced and the operational difficulties of medical staff are difficult, and the stability and safety of drug administration are improved.
Smart Images

Figure CN221932328U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of methods or equipment for treating eyes, in particular to an intraocular injection device. Background Art
[0002] Intraocular injection is a common method for treating eye-related diseases, especially for treating intraocular diseases (retinal vein occlusion, diabetic retinopathy, choroidal neovascularization, age-related macular degeneration, endophthalmitis, etc.). Usually during the injection, the doctor observes the patient's eye condition through a microscope and manually injects the drug into the eye.
[0003] With the advancement of technology, some commercial drugs (Ranibinib injection, Conbercept injection, etc.) will provide pre-filled products for direct injection, but for infectious diseases, doctors need to prepare the drugs themselves and use a handheld syringe for intraocular injection. During the injection process, the needle needs to be inserted into the patient's eye. If the drug cannot be delivered at a constant pressure or in a uniform amount, the patient will need to endure repeated puncture pain, and there is also the risk of perforating the eyeball. Utility Model Content
[0004] The utility model aims to provide an intraocular injection device to solve the technical problem of the non-continuous drug delivery process during intraocular injection of the eyeball in the prior art.
[0005] According to one aspect of the utility model, an intraocular injection device is provided, including a device body, in which a transmission assembly and a push rod cooperating with the transmission assembly are arranged; the push rod movable sleeve is arranged in a negative pressure chamber; the transmission assembly includes a first rack, a first gear meshing with the first rack, a second gear coaxially arranged on the axis of the first gear, and a second rack meshing with the second gear.
[0006] The coordinated transmission of the gear rack is set to ensure a stable transmission ratio, thereby effectively ensuring the continuous and stable push-in of the injected drug, achieving stable intraocular injection, reducing the patient's pain, and helping to reduce the difficulty of operation for medical staff.
[0007] In some embodiments, the device body further includes a handle, in which a driving member is disposed, and a torsion spring elastically connected to the driving member; during operation, the driving member presses inward to cause the torsion spring to deform.
[0008] In some embodiments, the torsion spring is elastically connected to the first rack.
[0009] In some embodiments, the end of the driving member is abutted against a turntable inside the device body.
[0010] In some embodiments, the device body further includes an auxiliary grip groove, which is disposed between the handles.
[0011] In some embodiments, a flexible pad is provided at the end of the negative pressure chamber.
[0012] In some embodiments, an injection needle is detachably connected to the end of the negative pressure chamber, and the injection needle passes through the flexible pad.
[0013] In some embodiments, a counterweight is also provided on the device body.
[0014] Compared with the prior art, the utility model has the following advantages and beneficial effects:
[0015] 1. The utility model realizes effective control of the drug administration process by setting a transmission component, and at the same time utilizes the stability of the gear rack transmission process to help improve the uniformity of drug administration, reduce the pain of patients and the difficulty of medical operation;
[0016] 2. The utility model sets a driving member and a torsion spring as the initial driving components to achieve low-loss transmission of the gripping force of the medical staff, and to maximize the best effect of transmitting the force to the first rack after the torsion spring is deformed. BRIEF DESCRIPTION OF THE DRAWINGS
[0017] In order to more clearly illustrate the embodiments of the utility model or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the utility model. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0018] Figure 1 It is an axonometric view of some embodiments of the utility model;
[0019] Figure 2 It is a schematic diagram of the internal structure of some embodiments of the utility model;
[0020] Figure 3 It is a partial enlarged view I of some embodiments of the utility model.
[0021] Legend:
[0022] 1- Equipment body; 11- Counterweight; 12- Push rod; 13- Transmission assembly; 131- First rack; 132- Second rack; 133- First gear; 134- Second gear; 14- Torsion spring; 15- Rotary disk; 16- Driving member; 17- Auxiliary grip groove; 2- Negative pressure chamber; 3- Flexible pad; 4- Injection needle. In order to avoid interference with technical features, the attached Figure 1-3Some technical features in the middle are guided by dotted lines. DETAILED DESCRIPTION
[0023] The technical solutions in the embodiments of the utility model will be described clearly and completely below in conjunction with the drawings in the embodiments of the utility model. Obviously, the described embodiments are only a part of the embodiments of the utility model, rather than all the embodiments. The following description of at least one exemplary embodiment is actually only illustrative and is by no means a limitation on the utility model and its application or use. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model. It should be noted that similar numbers and letters represent similar items in the following drawings, so once an item is defined in one drawing, it does not need to be further defined and explained in subsequent drawings.
[0024] This embodiment provides an intraocular injection device, which has been in the stage of in-hospital simulation test use. Figure 1-3 Give a description.
[0025] Example 1
[0026] This embodiment provides an intraocular injection device, including a device body 1, in which a transmission assembly 13 and a push rod 12 cooperating with the transmission assembly 13 are arranged; the push rod 12 is movably sleeved in a negative pressure chamber 2. The push rod 12 and the negative pressure chamber 2 form a liquid medicine delivery structure to deliver the injection liquid medicine.
[0027] Reference Figure 2 and 3 The transmission assembly 13 includes a first rack 131, a first gear 133 meshing with the first rack 131, a second gear 134 coaxially arranged on the axis of the first gear 133, and a second rack 132 meshing with the second gear 134. In actual operation, the first rack 131 will generate tension due to the deformation of the torsion spring 14, and move up and down in space. When the first rack 131 moves downward, it will drive the first gear 133 meshing with it to rotate counterclockwise. When the first gear 133 rotates counterclockwise, it will drive the second gear 134 coaxially arranged with it to rotate counterclockwise together. When the second gear 134 rotates counterclockwise, it will drive the second rack 132 to move rightward, that is, to move the push rod 12 in the negative pressure chamber 2.
[0028] Example 2
[0029] This embodiment only provides content that is different from that of Embodiment 1, and the rest of the similarities are not repeated. The device body 1 also includes a handle, in which a driving member 16 is provided, and a torsion spring 14 elastically connected to the driving member 16; during operation, the driving member 16 presses inward to drive the torsion spring 14 to deform. The torsion spring 14 is elastically connected to the first rack 131. It should be noted that the driving member 16 is elastically connected to the torsion spring 14 to ensure the effective transmission of the grip force. For other results or usage environments, a multi-link structure can be used.
[0030] Example 3
[0031] This embodiment only provides the contents different from those in Embodiments 1 and 2, and the other similarities are not repeated. The end of the driving member 16 is abutted against the rotating disk 15 in the device body 1. The abutment is set to ensure that after the driving member 16 is pressed inward, the rotating disk 15 can promptly push the driving member 16 outward. In order to achieve the above function, the rotating disk 15 in this embodiment is set to be self-rotating.
[0032] Example 4
[0033] This embodiment only provides content that is different from Embodiments 1 and 3, and the rest of the similarities are not repeated. The device body 1 also includes an auxiliary grip groove 17, and the auxiliary grip groove 17 is arranged at intervals between the grips. A flexible pad 3 is sleeved on the end of the negative pressure chamber 2. An injection needle 4 is detachably connected to the end of the negative pressure chamber 2, and the injection needle 4 passes through the flexible pad 3. It should be noted that the flexible pad 3 has two functions during actual use. One is to reduce the patient's sense of oppression and tension when facing the needle close to the eyes, and the other is to assist in improving the stability of the injection device. During operation, the flexible pad 3 can be partially abutted against the patient's eyes, that is, the facial area around the eyes.
[0034] Example 5
[0035] This embodiment only provides the contents different from the embodiment 1, and the other similarities are not repeated. A counterweight block 11 is also provided on the device body 1.
[0036] Although some specific embodiments of the present invention have been described in detail by way of examples, it should be understood by those skilled in the art that the above examples are for illustration only and are not intended to limit the scope of the present invention. It should be understood by those skilled in the art that the above embodiments may be modified or some technical features may be replaced by equivalents without departing from the scope and spirit of the present invention. The scope of the present invention is defined by the appended claims.
Claims
1. An intraocular injection device, characterized in that: The invention comprises a device body (1), wherein a transmission assembly (13) and a push rod (12) cooperating with the transmission assembly (13) are arranged in the device body (1); the push rod (12) is movably sleeved in a negative pressure chamber (2); the transmission assembly (13) comprises a first rack (131), a first gear (133) meshing with the first rack (131) for movement, a second gear (134) coaxially arranged on the axis of the first gear (133), and a second rack (132) meshing with the second gear (134).
2. An intraocular injection device according to claim 1, characterized in that: The device body (1) also includes a handle, in which a driving member (16) is arranged, and a torsion spring (14) of the driving member (16) is elastically connected; during operation, the driving member (16) is pressed inward to drive the torsion spring (14) to deform.
3. An intraocular injection device according to claim 2, characterized in that: The torsion spring (14) is elastically connected to the first rack (131).
4. An intraocular injection device according to claim 2, characterized in that: The end of the driving member (16) is abutted against a rotating disk (15) in the device body (1).
5. An intraocular injection device according to claim 2, characterized in that: The device body (1) further comprises an auxiliary grip groove (17), and the auxiliary grip groove (17) is arranged to be spaced apart from the grip.
6. An intraocular injection device according to claim 1, characterized in that: A flexible cushion block (3) is sleeved on the end of the negative pressure chamber (2).
7. An intraocular injection device according to claim 6, characterized in that: An injection needle (4) is detachably connected to the end of the negative pressure chamber (2), and the injection needle (4) passes through the flexible cushion block (3).
8. An intraocular injection device according to claim 1, characterized in that: A counterweight block (11) is also provided on the equipment body (1).
